Patent holdings for IPC class C07D 333/78

Total number of patents in this class: 196

10-year publication summary

6
18
20
10
14
13
5
15
9
4
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Merck Patent GmbH
5669
16
Sumitomo Chemical Company, Limited
9015
6
PGI Drug Discovery LLC
32
6
JSR Corporation
2530
5
eFFECTOR Therapeutics, Inc.
67
5
Enyo Pharma
54
5
FUJIFILM Corporation
30327
4
Duk San Neolux Co., Ltd.
691
4
Osaka University
3289
4
Sunovion Pharmaceuticals Inc.
247
4
Ryvu Therapeutics SA
47
4
Golgi Neurosciences S.r.l.
5
4
Syngenta Participations AG
1568
3
Board of Regents, The University of Texas System
6065
3
Promega Corporation
589
3
UCB Biopharma SRL
599
3
Jiangxi Jemincare Group Co., Ltd
66
3
Shanghai Jemincare Pharmaceuticals Co., Ltd
24
3
Samsung Display Co., Ltd.
38092
2
LG Chem, Ltd.
17883
2
Other owners 107